Table 1.
Clinical variables before and after atorvastatin treatment.
| Characteristics | Before Treatment | After treatment | p-value |
|---|---|---|---|
| age (years) | 36.0 ± 5.8 | 37.0 ± 5.8 | |
| Number (male number) | 10 (7) | 10 (7) | |
| BMI (kg/m2) | 23.4 ± 2.0 | n.d. | |
| FpG (mg/dl) | 88.6 ± 0.2 | n.d. | |
| hba1c (%) | 5.0 ± 0.8 | n.d. | |
| SBp (mmhg) | 126.2 ± 7.5 | 124.8 ± 5.3 | 0.132 |
| DBp (mmhg) | 76.6 ± 5.0 | 75.2 ± 3.3 | 0.153 |
| T-chol (mg/dl) | 224.0 ± 39.7 | 177.6 ± 15.2 | 0.012 |
| TG (mg/dl) | 166.6 ± 12.8 | 146.8 ± 7.8 | <0.001 |
| LDL-C (mg/dl) | 172.0 ± 13.4 | 105.8 ± 15.4 | <0.001 |
| hDL-C (mg/dl) | 39.0 ± 3.7 | 42.4 ± 2.6 | <0.001 |
| Creatinine (mg/dl) | 0.77 ± 0.06 | 0.77 ± 0.06 | 0.343 |
| eGFR (ml/min) | 85.0 ± 9.1 | 84.7 ± 8.7 | 0.376 |
| proteinuria (g/day) | 1.13 ± 0.20 | 0.79 ± 0.14 | <0.001 |
| aGes (U/ml) | 13.2 ± 1.4 | 10.5 ± 1.2 | <0.001 |
Data are shown as mean ± SD. n.d., not determined.